Related Experiment Video
Updated: Jul 12, 2026

The Aortic Ring Co-culture Assay: A Convenient Tool to Assess the Angiogenic Potential of Mesenchymal Stromal Cells In Vitro
Published on: September 18, 2017
Mitogenic activity in connection with coronary angioplasty
S R Johansson1, J Nilsson, A Hamsten
1Division of Cardiology, Sahlgrenska Hospital, University of Göteborg, Sweden.
Insights
Plasma mitogenic activity significantly increases immediately after percutaneous transluminal coronary angioplasty (PTCA). However, this acute rise in mitogenic activity does not correlate with the development of restenosis following the procedure.
Area of Science:
- Cardiovascular Research
- Vascular Biology
- Interventional Cardiology
Background:
- Percutaneous transluminal coronary angioplasty (PTCA) is a common procedure to treat coronary artery disease.
- Restenosis, the re-narrowing of a blood vessel after angioplasty, remains a significant clinical challenge.
- Plasma mitogenic activity, a marker of cellular proliferation, has been investigated for its role in vascular healing and restenosis.
Purpose of the Study:
- To investigate the temporal changes in plasma mitogenic activity following PTCA.
- To determine the relationship between post-PTCA plasma mitogenic activity and the occurrence of restenosis.
- To compare plasma mitogenic activity in patients undergoing PTCA versus those undergoing diagnostic coronary angiography.
Main Methods:
- Plasma samples were collected from 50 patients before and at multiple time points after elective PTCA (1h, 24h, 2 weeks, 6 months).
- Mitogenic activity was assessed by measuring the incorporation of 3H-thymidine into arterial smooth muscle cells incubated with patient plasma.
- Follow-up coronary angiography was performed to assess for restenosis at 6 months or earlier if clinically indicated. A control group of 17 patients underwent angiography without PTCA.
Main Results:
- Plasma mitogenic activity was significantly elevated 1 hour after PTCA compared to pre-procedure levels (53.1 +/- 7.4 vs 26.8 +/- 7.3, P < 0.001).
- Mitogenic activity returned to baseline levels by 24 hours and remained unchanged at later time points.
- No significant increase in mitogenic activity was observed in patients undergoing coronary angiography without PTCA.
- There was no significant difference in plasma mitogenic activity between patients who developed restenosis (n=19) and those who did not (n=31).
Conclusions:
- Plasma mitogenic activity shows a transient, acute increase immediately following PTCA.
- This immediate post-procedural surge in mitogenic activity is not associated with the development of restenosis.
- The findings suggest that factors other than this acute mitogenic response are likely responsible for restenosis after PTCA.
Abstract:
The aim of this study was to assess the plasma mitogenic activity in connection with percutaneous transluminal coronary angioplasty (PTCA) and the relation to restenosis. Plasma samples were taken on the morning before, 1 and 24 h after, 2 weeks after and 6 months after elective PTCA in 50 patients. Follow-up coronary angiography was carried out after 6 months or earlier if clinically warranted. Samples were also taken from 17 patients undergoing coronary angiography without PTCA. The mitogenic activity, expressed as the fraction of labelled nuclei after incubation of arterial smooth muscle cells with plasma in the presence of 3H-thymidine, was higher 1 h after PTCA than before (53.1 +/- 7.4 vs 26.8 +/- 7.3, P < 0.001). Later values were not elevated and no increase was seen after coronary angiography. The groups with (n = 19) and without (n = 31) restenosis did not differ in mitogenic activity. These results indicate that the plasma level of mitogenic activity increases immediately after PTCA. The pathophysiological significance of this increase for the development of restenosis is unclear, since the magnitude of the increase does not seem to be related to restenosis.
More Related Videos
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Related Concept Videos
Mechanism of Angiogenesis
Regulation of Angiogenesis and Blood Supply
Myocarditis III: Medical Management